Alzheimer's

Monoclonal antibody marks first approved Alzheimer’s treatment in nearly twenty years

Earlier this week, the pharmaceutical companies Biogen and Eisai announced encouraging results from a clinical trial for patients with Alzheimer’s disease: a monoclonal antibody treatment, called lecanemab, reduced cognitive decline by 27% in people with early-stage Alzheimer’s compared with those on a placebo after a year and a half. Outside observers say the trial could […]

Monoclonal antibody marks first approved Alzheimer’s treatment in nearly twenty years Read More »

New COVID-19 strain poses serious reinfection risk; The latest health stories from around the world

Health experts across the globe are signalling alarm as they begin reporting that Omicron BA.5, the coronavirus strain that is currently outpacing other variants in infection and has become the dominant strain in the United States (US) and abroad, has the ability to reinfect people within weeks of contracting the virus. Andrew Robertson, the chief

New COVID-19 strain poses serious reinfection risk; The latest health stories from around the world Read More »